These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4382039)

  • 41. Methotrexate. I. Pharmacology and pharmacokinetics.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human leukemia and normal leukocytes contain a species of immunoreactive but nonfunctional dihydrofolate reductase.
    Rothenberg SP; Iqbal MP
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):645-9. PubMed ID: 6952216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of nitrous oxide and methotrexate administration on hepatic methionine synthetase and dihydrofolate reductase activities, hepatic folates, and formate oxidation in rats.
    Black KA; Tephly TR
    Mol Pharmacol; 1983 May; 23(3):724-30. PubMed ID: 6865915
    [No Abstract]   [Full Text] [Related]  

  • 44. Dihydrofolate reductase from Escherichia coli: the kinetic mechanism with NADPH and reduced acetylpyridine adenine dinucleotide phosphate as substrates.
    Stone SR; Morrison JF
    Biochemistry; 1988 Jul; 27(15):5493-9. PubMed ID: 3052577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of conversion of phenylalanine-31 to leucine on the function of human dihydrofolate reductase.
    Prendergast NJ; Appleman JR; Delcamp TJ; Blakley RL; Freisheim JH
    Biochemistry; 1989 May; 28(11):4645-50. PubMed ID: 2765506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the topochemistry of dihydrofolate reductase.
    Onicescu D; Taşcă L
    Rom Med Rev; 1971; 15(2):9-15. PubMed ID: 5116410
    [No Abstract]   [Full Text] [Related]  

  • 47. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
    Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
    J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Refolding of Escherichia coli dihydrofolate reductase: sequential formation of substrate binding sites.
    Frieden C
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4413-6. PubMed ID: 2191290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assay of dihydrofolate reductase activity by monitoring tetrahydrofolate using high-performance liquid chromatography with electrochemical detection.
    Aiso K; Nozaki T; Shimoda M; Kokue E
    Anal Biochem; 1999 Aug; 272(2):143-8. PubMed ID: 10415082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crystal structures of Escherichia coli dihydrofolate reductase: the NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate binding and a model for the transition state.
    Bystroff C; Oatley SJ; Kraut J
    Biochemistry; 1990 Apr; 29(13):3263-77. PubMed ID: 2185835
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli: dihydrofolate monooxygenase activity.
    Poe M
    Biochem Biophys Res Commun; 1973 Oct; 54(3):1008-14. PubMed ID: 4584876
    [No Abstract]   [Full Text] [Related]  

  • 52. Kinetics of substrate, coenzyme, and inhibitor binding to Escherichia coli dihydrofolate reductase.
    Cayley PJ; Dunn SM; King RW
    Biochemistry; 1981 Feb; 20(4):874-9. PubMed ID: 7011378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance of Pediococcus cerevisiae to amethopterin as a consequence of changes in enzymatic activity and cell permeability. I. Dihydrofolate reductase, thymidylate synthetase and formyltetrahydrofolate synthetase in amethopterin-resistant and -sensitive strains of Pediococcus cerevisiae.
    Mandelbaum-Shavit F
    Biochim Biophys Acta; 1976 May; 428(3):664-73. PubMed ID: 6054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
    Matherly LH; Fry DW; Goldman ID
    Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age-dependent expression of a novel protein in mouse liver immunologically and functionally homologous with dihydrofolate reductase.
    Kyner D; Rothenberg SP
    Biochim Biophys Acta; 1989 Oct; 993(1):56-62. PubMed ID: 2804123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ability of methotrexate to inhibit translocation to the cytosol of dihydrofolate reductase fused to diphtheria toxin.
    Klingenberg O; Olsnes S
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):647-53. PubMed ID: 8573105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of chicken liver dihydrofolate reductase by tetrathionate.
    Barbehenn EK; Kaufman BT
    Biochem Biophys Res Commun; 1978 Nov; 85(1):402-7. PubMed ID: 743285
    [No Abstract]   [Full Text] [Related]  

  • 58. Dihydrofolate reductase: a coupled radiometric assay.
    Reyes P; Rathod PK
    Methods Enzymol; 1986; 122():360-7. PubMed ID: 3517568
    [No Abstract]   [Full Text] [Related]  

  • 59. Graphic methods for determination of Km and Ki values for dihydrofolate reductase.
    Freudenthal R
    Anal Biochem; 1970 Jun; 35(2):346-50. PubMed ID: 5450430
    [No Abstract]   [Full Text] [Related]  

  • 60. Percutaneous absorption of methotrexate.
    Newbold PC; Stoughton RB
    J Invest Dermatol; 1972 May; 58(5):319-22. PubMed ID: 5063355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.